273 related articles for article (PubMed ID: 25533034)
21. The miR-17-92 microRNA polycistron regulates MLL leukemia stem cell potential by modulating p21 expression.
Wong P; Iwasaki M; Somervaille TC; Ficara F; Carico C; Arnold C; Chen CZ; Cleary ML
Cancer Res; 2010 May; 70(9):3833-42. PubMed ID: 20406979
[TBL] [Abstract][Full Text] [Related]
22. Developmental stage-specific interplay of GATA1 and IGF signaling in fetal megakaryopoiesis and leukemogenesis.
Klusmann JH; Godinho FJ; Heitmann K; Maroz A; Koch ML; Reinhardt D; Orkin SH; Li Z
Genes Dev; 2010 Aug; 24(15):1659-72. PubMed ID: 20679399
[TBL] [Abstract][Full Text] [Related]
23. Oncogenic Gata1 causes stage-specific megakaryocyte differentiation delay.
Juban G; Sakakini N; Chagraoui H; Cruz Hernandez D; Cheng Q; Soady K; Stoilova B; Garnett C; Waithe D; Otto G; Doondeea J; Usukhbayar B; Karkoulia E; Alexiou M; Strouboulis J; Morrissey E; Roberts I; Porcher C; Vyas P
Haematologica; 2021 Apr; 106(4):1106-1119. PubMed ID: 32527952
[TBL] [Abstract][Full Text] [Related]
24. Differential gene expression, GATA1 target genes, and the chemotherapy sensitivity of Down syndrome megakaryocytic leukemia.
Ge Y; Dombkowski AA; LaFiura KM; Tatman D; Yedidi RS; Stout ML; Buck SA; Massey G; Becton DL; Weinstein HJ; Ravindranath Y; Matherly LH; Taub JW
Blood; 2006 Feb; 107(4):1570-81. PubMed ID: 16249385
[TBL] [Abstract][Full Text] [Related]
25. A regulatory circuit comprising GATA1/2 switch and microRNA-27a/24 promotes erythropoiesis.
Wang F; Zhu Y; Guo L; Dong L; Liu H; Yin H; Zhang Z; Li Y; Liu C; Ma Y; Song W; He A; Wang Q; Wang L; Zhang J; Li J; Yu J
Nucleic Acids Res; 2014 Jan; 42(1):442-57. PubMed ID: 24049083
[TBL] [Abstract][Full Text] [Related]
26. miR-9 upregulation leads to inhibition of erythropoiesis by repressing FoxO3.
Zhang Y; Li L; Yu C; Senyuk V; Li F; Quigley JG; Zhu T; Qian Z
Sci Rep; 2018 Apr; 8(1):6519. PubMed ID: 29695725
[TBL] [Abstract][Full Text] [Related]
27. Germline GATA1s-generating mutations predispose to leukemia with acquired trisomy 21 and Down syndrome-like phenotype.
Hasle H; Kline RM; Kjeldsen E; Nik-Abdul-Rashid NF; Bhojwani D; Verboon JM; DiTroia SP; Chao KR; Raaschou-Jensen K; Palle J; Zwaan CM; Nyvold CG; Sankaran VG; Cantor AB
Blood; 2022 May; 139(21):3159-3165. PubMed ID: 34758059
[TBL] [Abstract][Full Text] [Related]
28. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
29. Down syndrome-associated haematopoiesis abnormalities created by chromosome transfer and genome editing technologies.
Kazuki Y; Yakura Y; Abe S; Osaki M; Kajitani N; Kazuki K; Takehara S; Honma K; Suemori H; Yamazaki S; Sakuma T; Toki T; Shimizu R; Nakauchi H; Yamamoto T; Oshimura M
Sci Rep; 2014 Aug; 4():6136. PubMed ID: 25159877
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-223 dose levels fine tune proliferation and differentiation in human cord blood progenitors and acute myeloid leukemia.
Gentner B; Pochert N; Rouhi A; Boccalatte F; Plati T; Berg T; Sun SM; Mah SM; Mirkovic-Hösle M; Ruschmann J; Muranyi A; Leierseder S; Argiropoulos B; Starczynowski DT; Karsan A; Heuser M; Hogge D; Camargo FD; Engelhardt S; Döhner H; Buske C; Jongen-Lavrencic M; Naldini L; Humphries RK; Kuchenbauer F
Exp Hematol; 2015 Oct; 43(10):858-868.e7. PubMed ID: 26163797
[TBL] [Abstract][Full Text] [Related]
31. The miR-17-92 cluster expands multipotent hematopoietic progenitors whereas imbalanced expression of its individual oncogenic miRNAs promotes leukemia in mice.
Li Y; Vecchiarelli-Federico LM; Li YJ; Egan SE; Spaner D; Hough MR; Ben-David Y
Blood; 2012 May; 119(19):4486-98. PubMed ID: 22451425
[TBL] [Abstract][Full Text] [Related]
32. The abundance of the short GATA1 isoform affects megakaryocyte differentiation and leukemic predisposition in mice.
Ishihara D; Hasegawa A; Hirano I; Engel JD; Yamamoto M; Shimizu R
Exp Hematol Oncol; 2024 Feb; 13(1):24. PubMed ID: 38409186
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-29a and microRNA-142-3p are regulators of myeloid differentiation and acute myeloid leukemia.
Wang XS; Gong JN; Yu J; Wang F; Zhang XH; Yin XL; Tan ZQ; Luo ZM; Yang GH; Shen C; Zhang JW
Blood; 2012 May; 119(21):4992-5004. PubMed ID: 22493297
[TBL] [Abstract][Full Text] [Related]
34. Developmental stage-selective effect of somatically mutated leukemogenic transcription factor GATA1.
Li Z; Godinho FJ; Klusmann JH; Garriga-Canut M; Yu C; Orkin SH
Nat Genet; 2005 Jun; 37(6):613-9. PubMed ID: 15895080
[TBL] [Abstract][Full Text] [Related]
35. GATA1 and cooperating mutations in myeloid leukaemia of Down syndrome.
Garnett C; Cruz Hernandez D; Vyas P
IUBMB Life; 2020 Jan; 72(1):119-130. PubMed ID: 31769932
[TBL] [Abstract][Full Text] [Related]
36. Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling.
Bourquin JP; Subramanian A; Langebrake C; Reinhardt D; Bernard O; Ballerini P; Baruchel A; Cavé H; Dastugue N; Hasle H; Kaspers GL; Lessard M; Michaux L; Vyas P; van Wering E; Zwaan CM; Golub TR; Orkin SH
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3339-44. PubMed ID: 16492768
[TBL] [Abstract][Full Text] [Related]
37. Valproic acid regulates erythro-megakaryocytic differentiation through the modulation of transcription factors and microRNA regulatory micro-networks.
Trécul A; Morceau F; Gaigneaux A; Schnekenburger M; Dicato M; Diederich M
Biochem Pharmacol; 2014 Nov; 92(2):299-311. PubMed ID: 25241289
[TBL] [Abstract][Full Text] [Related]
38. Ferritin Heavy Subunit Silencing Blocks the Erythroid Commitment of K562 Cells via miR-150 up-Regulation and GATA-1 Repression.
Zolea F; Battaglia AM; Chiarella E; Malanga D; De Marco C; Bond HM; Morrone G; Costanzo F; Biamonte F
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29039805
[TBL] [Abstract][Full Text] [Related]
39. Gata1s mutant mice display persistent defects in the erythroid lineage.
Ling T; Zhang K; Yang J; Gurbuxani S; Crispino JD
Blood Adv; 2023 Jul; 7(13):3253-3264. PubMed ID: 36350717
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-155-5p Plays a Critical Role in Transient Leukemia of Down Syndrome by Targeting Tumor Necrosis Factor Receptor Superfamily Members.
Sas V; Pasca S; Jurj A; Pop L; Muramatsu H; Ono H; Dima D; Teodorescu P; Iluta S; Turcas C; Onaciu A; Munteanu R; Zimta AA; Blag C; Popa G; von Gamm EDA; Arghirescu S; Serban M; Man S; Marian M; Petrushev B; Berce C; Colita A; Zdrenghea M; Kojima S; Gulei D; Takahashi Y; Tomuleasa C
Cell Physiol Biochem; 2020 Oct; 54(5):994-1012. PubMed ID: 33006449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
